Articular ¹⁸Fluorodeoxyglucose Uptake Is Associated With Clinically Assessed Swollen Joint Count in Patients With Rheumatoid Arthritis

REFERENCES

1. 1.↵
   1. Aletaha D,
   2. Smolen JS

   . The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin North Am 2006;32:9-44.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Prevoo ML,
   2. van ’t Hof MA,
   3. Kuper HH,
   4. van Leeuwen MA,
   5. van de Putte LB,
   6. van Riel PL

   . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Aletaha D,
   2. Smolen J

   . The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005;23:S100-8.

   OpenUrlPubMed
4. 4.↵
   1. Mäkinen H,
   2. Kautiainen H,
   3. Hannonen P,
   4. Sokka T

   . Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 2005;64:1410-3.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Brown AK,
   2. Quinn MA,
   3. Karim Z, et al.

   Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006;54:3761-73.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Baker JF,
   2. Conaghan PG,
   3. Gandjbakhch F

   . Update on magnetic resonance imaging and ultrasound in rheumatoid arthritis. Clin Exp Rheumatol 2018;36 Suppl 114:16-23.

   OpenUrl
7. 7.↵
   1. Aletaha D,
   2. Neogi T,
   3. Silman AJ, et al.

   2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Amigues I,
   2. Tugcu A,
   3. Russo C, et al.

   Myocardial inflammation, measured using 18-fluorodeoxyglucose positron emission tomography with computed tomography, is associated with disease activity in rheumatoid arthritis. Arthritis Rheumatol 2019; 71:496-506.

   OpenUrl
9. 9.↵
   1. Coskun Benlidayi I

   . Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases. Rheumatology Int 2020;40:849-58.

   OpenUrl
10. 10.↵
    1. Chaudhari AJ,
    2. Ferrero A,
    3. Godinez F, et al.

    High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study. Br J Radiol 2016;89:20160138.

    OpenUrl
11. 11.↵
    1. Bhattarai A,
    2. Nakajima T,
    3. Sapkota S, et al.

    Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis. Medicine 2017;96:e7130.

    OpenUrl
12. 12.↵
    1. Suto T,
    2. Okamura K,
    3. Yonemoto Y,
    4. Okura C,
    5. Tsushima Y,
    6. Takagishi K

    . Prediction of large joint destruction in patients with rheumatoid arthritis using 18F-FDG PET/CT and disease activity score. Medicine 2016;95:e2841.

    OpenUrl
13. 13.↵
    1. Okamura K,
    2. Yonemoto Y,
    3. Okura C,
    4. Higuchi T,
    5. Tsushima Y,
    6. Takagishi K

    . Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT. BMC Musculoskelet Disord 2014;15:393.

    OpenUrl
14. 14.↵
    1. Okamura K,
    2. Yonemoto Y,
    3. Arisaka Y, et al.

    The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology 2012;51:1484-91.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Roivainen A,
    2. Hautaniemi S,
    3. Möttönen T, et al.

    Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs. Eur J Nucl Med Mol Imaging 2013;40:403-10.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Lee SJ,
    2. Jeong JH,
    3. Lee CH, et al.

    Development and validation of an 18F-fluorodeoxyglucose–positron emission tomography with computed tomography–based tool for the evaluation of joint counts and disease activity in patients with rheumatoid arthritis. Arthritis Rheumatol 2019;71:1232-40.

    OpenUrl